Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Chloroquine

Cardiomyopathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a report of 5 females, a female patient [age not stated] was described, who developed cardiomyopathy following treatment with chloroquine [dosage, route and duration of treatment to reaction onset not stated] for systemic lupus erythematosus. Cardiac biopsy was consistent with chloroquine cardiomyopathy. Genetic screening for Fabry disease was negative. During the follow up, the progression of cardiomyopathy into heart failure was noted, and then she underwent a successful heart transplantation. However, she subsequently died due to heart transplant rejection. …
Literatur
Zurück zum Zitat Hedvig Takacs H, et al. Chloroquin cardiomyopathy manifested as hypertrophic cardiomyopathy. European Journal of Heart Failure 21 (Suppl. 1): 287-288 abstr. P1164, May 2019. Available from: URL: http://doi.org/10.1002/ejhf.1488 [abstract] - Hungary Hedvig Takacs H, et al. Chloroquin cardiomyopathy manifested as hypertrophic cardiomyopathy. European Journal of Heart Failure 21 (Suppl. 1): 287-288 abstr. P1164, May 2019. Available from: URL: http://​doi.​org/​10.​1002/​ejhf.​1488 [abstract] - Hungary
Metadaten
Titel
Chloroquine
Cardiomyopathy: case report
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65857-6

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Antineoplastics

Case report

Colistin

Case report

Rituximab